Real-world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients.

William C CranwellNekma MeahDmitri WallBevin BhoyrulBokhari LaitaRodney Daniel Sinclair

Published in: The Australasian journal of dermatology (2024)

Tofacitinib was a safe and effective treatment for patients with moderate-to-severe AA. Further randomised controlled studies are needed to establish the optimal treatment regimen.

Keyphrases

rheumatoid arthritis
randomized controlled trial
clinical trial
early onset
replacement therapy